1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Comparison between ipsilateral and contralateral asymptomatic plaques: results of Wilcoxon signed rank tests
Plaques Ipsilateral to the Symptomatic Side (Mean Value ± SE) Contralateral Asymptomatic Plaques (Mean Value ± SE) P Value
Degree of stenosis according to NASCET method⁶ (%) 37.1 ± 2.1 16.1 ± 2.9 <.001
Mean TBR 
    All patients (N = 50) 1.19 ± 0.03 1.17 ± 0.04 .318
    Only patients in whom ¹⁸F-FDG PET/MDCT was performed within 38 days after symptoms (n = 38) 1.24 ± 0.04 1.17 ± 0.05 .014
Maximum TBR 
    All patients (N = 50) 1.46 ± 0.05 1.44 ± 0.06 .160
    Only patients in whom ¹⁸F-FDG PET/MDCT was performed within 38 days after symptoms (n = 38) 1.53 ± 0.06 1.42 ± 0.06 .015
Vessel wall volume (mm³) 982.3 ± 121.3 811.3 ± 106.6 .016
LRNC volume (mm³) 164.7 ± 26.1 134.3 ± 35.2 .026
Volume of fibrous tissue (mm³) 491.2 ± 56.2 430.5 ± 49.9 .081
Volume of calcifications (mm³) 312.4 ± 61.6 246.9 ± 45.8 .067